Literature DB >> 31083266

Failure of 3 different methods and biopsy sites to diagnose a patient with invasive colorectal cancer: A case report.

Daniel Dongiu Kim1, Kyle Joseph Litow2, Thomas James Lumbra3, Mohammad Milhim Masri2.   

Abstract

RATIONALE: Colorectal cancer is one of the most commonly diagnosed cancers worldwide, and the majority arise from neoplastic adenomatous polyps. Bladder involvement in colorectal cancer is uncommon and found in approximately 3% of the cases, most commonly in sigmoid and rectal tumors and the diagnosis is classically based on biopsies of affected tissues. PATIENT CONCERNS: A 68-year-old male with no significant past medical history underwent diagnostic colonoscopy for abdominal distension and constipation with positive fecal occult blood test ordered by the primary care physician. DIAGNOSIS: Colonoscopy showed a sigmoid mass with biopsy finding of tubulovillous adenoma. Laparoscopy was performed for sigmoid colonic resection, but as the mass was large, a diverting loop colostomy and multiple biopsies were performed revealing tubulovillous adenoma again. Postoperative workup revealed right hydronephrosis, and cystoscopy was performed confirming bladder wall invasion with biopsies showing benign bladder wall tissue with no evidence of dysplasia or malignancy. Furthermore, computed tomography (CT)-guided core-needle biopsies of the colonic mass were performed but revealed adenomatous colonic mucosa without evidence of carcinoma. INTERVENTION: Definitive surgical en bloc excision of the tumor and anterior bladder wall was performed with urology team until grossly free margins were attained. Final pathology revealed well-differentiated mucinous adenocarcinoma arising from a preexisting tubulovillous adenoma with direct invasion of the bladder wall. OUTCOMES: The patient's postoperative recovery was uneventful, and he was discharged 2 weeks postoperatively with planned adjuvant chemotherapy. LESSONS: This case represents a classical presentation of invasive colorectal cancer. Perioperative workup, however, was confounded by failure of open, cystoscopic, and CT-guided biopsies to establish a tissue diagnosis for directed therapy. Upon literature review, evidence exists to support our approach to this unique dilemma.

Entities:  

Mesh:

Year:  2019        PMID: 31083266      PMCID: PMC6531124          DOI: 10.1097/MD.0000000000015656

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Colorectal cancer is one of the most commonly diagnosed cancers worldwide with marked geographic differences in incidence. Despite its high incidence, mortality has decreased in many countries since 1990.[ This improving mortality rate is closely related with increasing populational screening,[ and therefore only up to 10% of cases present as invasive colorectal carcinoma (AJCC stage pT4).[ The most common diagnostic test for colorectal carcinoma is tissue biopsy during colonoscopy and its sensitivity has been reported to be as high as 87%.[ In invasive colorectal carcinoma cases, preoperative diagnosis by pelvic CT scan or magnetic resonance imaging is often limited due to difficulty in distinguishing between invasive disease and local inflammation.[ In this report, we discuss the importance of clinical suspicion for colorectal cancer diagnosis even with multiple negative biopsies from different sites and how en bloc excision of tumoral mass was seminal for diagnosis and initial treatment of this case.[

Case report

A 68-year-old Hispanic male with no significant past medical history underwent diagnostic colonoscopy for abdominal distension and constipation with positive fecal occult blood. During colonoscopy he was found to have a sigmoid mass, and he presented to our general surgery office for colonoscopy biopsy findings of tubulovillous adenoma with focal high-grade dysplasia. During diagnostic laparoscopy for planned sigmoid colonic resection, a large 10 × 10 × 15 cm sigmoid colonic mass was discovered and noted to be fixed in the pelvis and invading the bladder wall. Due to the size of the mass and indeterminate diagnosis, a diverting loop colostomy was performed for obstructive symptoms, and multiple biopsies were performed. Surgical pathology revealed tubulovillous adenoma and benign tubular adenomas. Furthermore, postoperative workup revealed right hydronephrosis, and cystoscopy performed 3 days postoperatively confirmed bladder wall invasion; bilateral ureteral stents were placed, and biopsies of the bladder were performed. Pathology revealed benign bladder wall tissue with no evidence of dysplasia or malignancy. Computed tomography (CT)-guided core-needle biopsies were subsequently performed to establish the diagnosis and direct therapy (Figs. 1 and 2). Pathology from these biopsies revealed adenomatous colonic mucosa without evidence of carcinoma. Finally, definitive surgical resection was performed 2 months after initial colonoscopy to excise the obstructing tumor and establish a definitive diagnosis. An en bloc excision of the tumor and anterior bladder wall was performed with urology until grossly free margins were attained; the previous colostomy was left in place, the bladder wall was repaired primarily with ureteral stents left in place, and approximately 10 cm of intraabdominal large bowel remained distally. Final pathology revealed well-differentiated mucinous adenocarcinoma arising from a preexisting tubulovillous adenoma with direct invasion of the bladder wall and histological free margins in the resected tumor (Figs. 3 and 4). The patient's postoperative recovery was uneventful, and he was discharged 2 weeks postoperatively with planned adjuvant chemotherapy.
Figure 1

Sagittal abdominal computed tomography scan showing the tumoral mass (blue) adjacent to the rectosigmoid colon and urinary bladder (red).

Figure 2

Axial abdominal computed scan showing the core biopsy needle inside the tumoral mass.

Figure 3

Pathology slide showing well-differentiated mucinous adenocarcinoma arising from a tubulovillous adenoma.

Figure 4

Pathology slide showing bladder wall with colonic adenocarcinoma tumor deposits.

Sagittal abdominal computed tomography scan showing the tumoral mass (blue) adjacent to the rectosigmoid colon and urinary bladder (red). Axial abdominal computed scan showing the core biopsy needle inside the tumoral mass. Pathology slide showing well-differentiated mucinous adenocarcinoma arising from a tubulovillous adenoma. Pathology slide showing bladder wall with colonic adenocarcinoma tumor deposits.

Discussion

Most colorectal cancers arise from neoplastic adenomatous polyps in a long-term carcinogenic process involving damage to proto-oncogenes and tumor suppressor genes.[ Sporadic nonhereditary colorectal cancer is the most common type.[ Despite the majority of colorectal cancer being located in the left colon and rectum, an increasing incidence of right-sided colon cancer has been reported.[ Approximately 10% of patients with colorectal cancer present with tumors with direct invasion or adherence of other organs.[ Bladder involvement in colorectal cancer is uncommon and found in approximately 3% of the cases, most commonly in sigmoid and rectal tumors.[ Cystoscopy has been reported to have a similar sensitivity to pelvic CT scan for identifying local bladder invasion, but may be a useful tool for surgical planning.[ The uniqueness of this case is not only the tumoral bladder involvement, but also 3 consecutive negative biopsies done by different methods: open, cystoscopic, and CT guided (Fig. 5).
Figure 5

Timeline of the tests performed with pathology results.

Timeline of the tests performed with pathology results. In cases of colorectal cancer with multivisceral disease, recommendations exist for en bloc resection due to favorable outcomes in margin negative tumors. Partial cystectomy in colorectal cancer with urinary bladder invasion has been shown to have similar survival rates with less morbidity compared with radical cystectomy in several case series.[ According to multiple studies, the 5-year survival rate of stage pT4 colon cancer treated with en bloc resection is around 50% with a local recurrence rate of <20%. Prognosis is directly affected by liver metastasis, lymph node invasion, positive resection margin, and the absence of microsatellite instability.[ In our case, failure of 3 separate biopsy techniques to establish a tissue diagnosis of invasive adenocarcinoma precluded the use of neoadjuvant chemotherapy, thereby rendering en bloc resection to be the treatment of choice. Had a tissue diagnosis of colonic adenocarcinoma been established, neoadjuvant chemotherapy would have been pursued in accordance with the National Comprehensive Cancer Network guidelines. Sensitivity of tissue biopsy for colorectal carcinoma during colonoscopy has been reported to be as high as 87%,[ but there is still possibility of missed diagnosis. As any clinical test there is an intrinsic failure rate which is estimated from 0.5 to 3.5 missed colorectal cancer cases per 1000 screening colonoscopies and commonly associated with missed lesions, incomplete resections, incomplete colonoscopy or inadequate bowel preparation.[ For those unfortunate enough to have a patient with similar inconclusive biopsy results, we hope our case may serve as an evidence for en bloc resection with grossly negative margins to achieve oncologically acceptable results.

Acknowledgments

We thank the urology, hematology/oncology, radiology and gastroenterology teams at Larkin Community Hospital South Miami campus for all of their help with the management of this case.

Author contributions

DDK was responsible for writing (review and editing), formal analysis, and investigation; KJL was responsible for writing (review and editing), methodology, formal analysis, and supervision; TJL was responsible for writing (original draft), investigation, and data curation; MMM was responsible for conceptualization, supervision, and formal analysis. Conceptualization: Mohammad Milhim Masri. Data curation: Thomas James Lumbra. Formal analysis: Daniel Dongiu Kim, Kyle Joseph Litow, Mohammad Milhim Masri. Investigation: Daniel Dongiu Kim, Thomas James Lumbra. Methodology: Kyle Joseph Litow. Supervision: Kyle Joseph Litow, Mohammad Milhim Masri. Writing – original draft: Thomas James Lumbra. Writing – review and editing: Daniel Dongiu Kim, Kyle Joseph Litow.
  14 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Authors:  Andrew M D Wolf; Elizabeth T H Fontham; Timothy R Church; Christopher R Flowers; Carmen E Guerra; Samuel J LaMonte; Ruth Etzioni; Matthew T McKenna; Kevin C Oeffinger; Ya-Chen Tina Shih; Louise C Walter; Kimberly S Andrews; Otis W Brawley; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Rebecca L Siegel; Richard C Wender; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

Review 3.  The missed colorectal cancer problem.

Authors:  S Faiss
Journal:  Dig Dis       Date:  2011-11-15       Impact factor: 2.404

4.  Continued change in the distribution of colorectal carcinoma.

Authors:  D I Obrand; P H Gordon
Journal:  Br J Surg       Date:  1998-02       Impact factor: 6.939

5.  En bloc urinary bladder resection for locally advanced colorectal cancer: a 17-year experience.

Authors:  Jimmy C M Li; Charing C N Chong; Simon S M Ng; Raymond Y C Yiu; Janet F Y Lee; Ka Lau Leung
Journal:  Int J Colorectal Dis       Date:  2011-04-28       Impact factor: 2.571

6.  Brush cytology for the diagnosis of colorectal cancer.

Authors:  Richard Brouwer; Alistair MacDonald; Ronnie Matthews; James Gunn; John R Monson; John E Hartley
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

Review 7.  To resect or not to resect: The hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer.

Authors:  Fabio Gelsomino; Andrea Spallanzani; Giulia Orsi; Francesco Caputo; Chiara Santini; Stefano Cascinu
Journal:  Crit Rev Oncol Hematol       Date:  2018-10-11       Impact factor: 6.312

Review 8.  Worldwide variations in colorectal cancer.

Authors:  Melissa M Center; Ahmedin Jemal; Robert A Smith; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2009 Nov-Dec       Impact factor: 508.702

9.  High incidence of urinary bladder involvement in carcinomas of the sigmoid and rectum: a retrospective review of 580 patients with colorectal carcinoma.

Authors:  Takashi Kobayashi; Toshiyuki Kamoto; Yoshio Sugino; Hideo Takeuchi; Tomonori Habuchi; Osamu Ogawa
Journal:  J Surg Oncol       Date:  2003-12       Impact factor: 3.454

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Christine Allen; Ryan M Barber; Lars Barregard; Zulfiqar A Bhutta; Hermann Brenner; Daniel J Dicker; Odgerel Chimed-Orchir; Rakhi Dandona; Lalit Dandona; Tom Fleming; Mohammad H Forouzanfar; Jamie Hancock; Roderick J Hay; Rachel Hunter-Merrill; Chantal Huynh; H Dean Hosgood; Catherine O Johnson; Jost B Jonas; Jagdish Khubchandani; G Anil Kumar; Michael Kutz; Qing Lan; Heidi J Larson; Xiaofeng Liang; Stephen S Lim; Alan D Lopez; Michael F MacIntyre; Laurie Marczak; Neal Marquez; Ali H Mokdad; Christine Pinho; Farshad Pourmalek; Joshua A Salomon; Juan Ramon Sanabria; Logan Sandar; Benn Sartorius; Stephen M Schwartz; Katya A Shackelford; Kenji Shibuya; Jeff Stanaway; Caitlyn Steiner; Jiandong Sun; Ken Takahashi; Stein Emil Vollset; Theo Vos; Joseph A Wagner; Haidong Wang; Ronny Westerman; Hajo Zeeb; Leo Zoeckler; Foad Abd-Allah; Muktar Beshir Ahmed; Samer Alabed; Noore K Alam; Saleh Fahed Aldhahri; Girma Alem; Mulubirhan Assefa Alemayohu; Raghib Ali; Rajaa Al-Raddadi; Azmeraw Amare; Yaw Amoako; Al Artaman; Hamid Asayesh; Niguse Atnafu; Ashish Awasthi; Huda Ba Saleem; Aleksandra Barac; Neeraj Bedi; Isabela Bensenor; Adugnaw Berhane; Eduardo Bernabé; Balem Betsu; Agnes Binagwaho; Dube Boneya; Ismael Campos-Nonato; Carlos Castañeda-Orjuela; Ferrán Catalá-López; Peggy Chiang; Chioma Chibueze; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Solomon Damtew; José das Neves; Suhojit Dey; Samath Dharmaratne; Preet Dhillon; Eric Ding; Tim Driscoll; Donatus Ekwueme; Aman Yesuf Endries; Maryam Farvid; Farshad Farzadfar; Joao Fernandes; Florian Fischer; Tsegaye Tewelde G/Hiwot; Alemseged Gebru; Sameer Gopalani; Alemayehu Hailu; Masako Horino; Nobuyuki Horita; Abdullatif Husseini; Inge Huybrechts; Manami Inoue; Farhad Islami; Mihajlo Jakovljevic; Spencer James; Mehdi Javanbakht; Sun Ha Jee; Amir Kasaeian; Muktar Sano Kedir; Yousef S Khader; Young-Ho Khang; Daniel Kim; James Leigh; Shai Linn; Raimundas Lunevicius; Hassan Magdy Abd El Razek; Reza Malekzadeh; Deborah Carvalho Malta; Wagner Marcenes; Desalegn Markos; Yohannes A Melaku; Kidanu G Meles; Walter Mendoza; Desalegn Tadese Mengiste; Tuomo J Meretoja; Ted R Miller; Karzan Abdulmuhsin Mohammad; Alireza Mohammadi; Shafiu Mohammed; Maziar Moradi-Lakeh; Gabriele Nagel; Devina Nand; Quyen Le Nguyen; Sandra Nolte; Felix A Ogbo; Kelechi E Oladimeji; Eyal Oren; Mahesh Pa; Eun-Kee Park; David M Pereira; Dietrich Plass; Mostafa Qorbani; Amir Radfar; Anwar Rafay; Mahfuzar Rahman; Saleem M Rana; Kjetil Søreide; Maheswar Satpathy; Monika Sawhney; Sadaf G Sepanlou; Masood Ali Shaikh; Jun She; Ivy Shiue; Hirbo Roba Shore; Mark G Shrime; Samuel So; Samir Soneji; Vasiliki Stathopoulou; Konstantinos Stroumpoulis; Muawiyyah Babale Sufiyan; Bryan L Sykes; Rafael Tabarés-Seisdedos; Fentaw Tadese; Bemnet Amare Tedla; Gizachew Assefa Tessema; J S Thakur; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Benjamin S Chudi Uzochukwu; Vasiliy Victorovich Vlassov; Elisabete Weiderpass; Mamo Wubshet Terefe; Henock Gebremedhin Yebyo; Hassen Hamid Yimam; Naohiro Yonemoto; Mustafa Z Younis; Chuanhua Yu; Zoubida Zaidi; Maysaa El Sayed Zaki; Zerihun Menlkalew Zenebe; Christopher J L Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2017-04-01       Impact factor: 31.777

View more
  1 in total

1.  Treatment efficacy and prognosis analysis in locally advanced or metastatic colorectal cancer patients with hydronephrosis.

Authors:  Gangling Tong; Boran Chen; Mingying Zhang; Tianyu Wang; Xuan Wu; Yuye Yan; Shubin Wang; Shuluan Li
Journal:  Mol Clin Oncol       Date:  2022-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.